| Takeda Pharma AG - Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 61636 | | 01 | | Cinryze 500 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B06AC01 | | C1-Inhibitor, Plasma Derived | | 23.05.2013 | | |
| | Composition | | Praeparatio cryodesiccata: C1-esterasi inhibitor humanus 500 U.I., natrii citras dihydricus, natrii chloridum, valinum, alaninum, threoninum, saccharum, pro vitro corresp. natrium 11.5 mg.
Solvens: aqua ad iniectabile, pro vitro. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| C1-esterasi Inhibitor Humanus | 500 UI |
| | BAG: Active Agent | Dose |
|---|
| C1-esterasi Inhibitor Humanus | 500 UI |
| | | | Inactive agents |
|---|
| Alanine | | Sodium Chloride | | Natrii Citras Dihydricus | | Saccharum | | Threonine | | Valine |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 2 x 500 / 0 UI | 1264.02 | 1337.90 | B | SL | No |
|
|
